Inspira Technologies Oxy BHN Ltd (IINN) - Net Assets
Based on the latest financial reports, Inspira Technologies Oxy BHN Ltd (IINN) has net assets worth $1.28 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.45 Million) and total liabilities ($3.17 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Inspira Technologies Oxy BHN Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.28 Million |
| % of Total Assets | 28.71% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 12.56 |
Inspira Technologies Oxy BHN Ltd - Net Assets Trend (2018–2024)
This chart illustrates how Inspira Technologies Oxy BHN Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Inspira Technologies Oxy BHN Ltd asset portfolio for the complete picture of this company's asset base.
Annual Net Assets for Inspira Technologies Oxy BHN Ltd (2018–2024)
The table below shows the annual net assets of Inspira Technologies Oxy BHN Ltd from 2018 to 2024. For live valuation and market cap data, see Inspira Technologies Oxy BHN Ltd stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $4.32 Million | -24.68% |
| 2023-12-31 | $5.74 Million | -55.25% |
| 2022-12-31 | $12.82 Million | -37.01% |
| 2021-12-31 | $20.35 Million | +1294.48% |
| 2020-12-31 | $-1.70 Million | +63.28% |
| 2019-12-31 | $-4.64 Million | -15903.45% |
| 2018-12-31 | $-29.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Inspira Technologies Oxy BHN Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 6654100000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $70.90 Million | 1640.35% |
| Total Equity | $4.32 Million | 100.00% |
Inspira Technologies Oxy BHN Ltd Competitors by Market Cap
The table below lists competitors of Inspira Technologies Oxy BHN Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Nortech Systems Incorporated
NASDAQ:NSYS
|
$20.26 Million |
|
Bangsaphan Barmill Public Company Limited
BK:BSBM
|
$20.27 Million |
|
Aseana Properties Limited
LSE:ASPL
|
$20.28 Million |
|
CCID Consulting Company Limited
F:CCX
|
$20.28 Million |
|
Cassius Mining Ltd
AU:CMD
|
$20.25 Million |
|
Lincoln Minerals Ltd
AU:LML
|
$20.24 Million |
|
Vow Green Metals AS
OL:VGM
|
$20.23 Million |
|
aap Implantate AG
F:AAQ1
|
$20.23 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Inspira Technologies Oxy BHN Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 5,738,000 to 4,322,000, a change of -1,416,000 (-24.7%).
- Net loss of 11,053 reduced equity.
- New share issuances of 7,898,000 increased equity.
- Other factors decreased equity by 9,302,947.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-11.05K | -0.26% |
| Share Issuances | $7.90 Million | +182.74% |
| Other Changes | $-9.30 Million | -215.25% |
| Total Change | $- | -24.68% |
Book Value vs Market Value Analysis
This analysis compares Inspira Technologies Oxy BHN Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.00x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | $-0.01 | $0.47 | x |
| 2019-12-31 | $-0.34 | $0.47 | x |
| 2020-12-31 | $-0.24 | $0.47 | x |
| 2021-12-31 | $3.84 | $0.47 | x |
| 2022-12-31 | $1.26 | $0.47 | x |
| 2023-12-31 | $0.47 | $0.47 | x |
| 2024-12-31 | $0.23 | $0.47 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Inspira Technologies Oxy BHN Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -0.26%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.87x
- Recent ROE (-0.26%) is above the historical average (-44.23%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-36.70K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.12 Million |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-7.06 Million |
| 2021 | -83.33% | 0.00% | 0.00x | 1.27x | $-19.00 Million |
| 2022 | -29.36% | 0.00% | -0.29x | 1.17x | $-5.37 Million |
| 2023 | -196.69% | 0.00% | 0.00x | 1.62x | $-11.86 Million |
| 2024 | -0.26% | 0.00% | 0.00x | 1.87x | $-443.25K |
Industry Comparison
This section compares Inspira Technologies Oxy BHN Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $2,432,799,891
- Average return on equity (ROE) among peers: -74.29%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Inspira Technologies Oxy BHN Ltd (IINN) | $1.28 Million | 0.00% | 2.48x | $20.25 Million |
| Abbott Laboratories (ABT) | $24.16 Billion | 9.46% | 0.81x | $155.56 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-13.54K | 0.00% | 0.00x | $21.60 Million |
| Aethlon Medical Inc (AEMD) | $9.29 Million | -84.45% | 0.15x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $105.73 Million | -116.68% | 0.61x | $903.35K |
| Adapthealth Corp (AHCO) | $15.14 Million | -140.98% | 14.05x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $2.15 Million | -112.84% | 0.45x | $16.04 Million |
| Allurion Technologies, Inc. (ALUR) | $-70.49 Million | 0.00% | 0.00x | $8.60 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $4.22 Million |
| Artivion Inc (AORT) | $89.39 Million | 8.74% | 0.25x | $1.73 Billion |
| Apyx Medical Inc (APYX) | $21.15 Million | 2.82% | 0.30x | $125.55 Million |
About Inspira Technologies Oxy BHN Ltd
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. The company was formerly known as In… Read more